These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22059101)

  • 21. Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
    Yarad EA; Hammond NE
    Aust Crit Care; 2013 Aug; 26(3):105-17. PubMed ID: 23806874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of magnesium sulfate on cerebral vasospasm in the treatment of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Zheng H; Guo X; Huang X; Xiong Y; Gao W; Ke C; Chen C; Pan Z; Ye L; Wang L; Hu W; Zheng F
    Front Neurol; 2023; 14():1249369. PubMed ID: 38020616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
    Germans MR; Dronkers WJ; Baharoglu MI; Post R; Verbaan D; Rinkel GJ; Roos YB
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001245. PubMed ID: 36350005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tirilazad for aneurysmal subarachnoid haemorrhage.
    Zhang S; Wang L; Liu M; Wu B
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).
    Leijenaar JF; Dorhout Mees SM; Algra A; van den Bergh WM; Rinkel GJ;
    Int J Stroke; 2015 Oct; 10 Suppl A100():108-12. PubMed ID: 26502971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.
    Dorhout Mees SM; Algra A; Wong GK; Poon WS; Bradford CM; Saver JL; Starkman S; Rinkel GJ; van den Bergh WM; ; van Kooten F; Dirven CM; van Gijn J; Vermeulen M; Rinkel GJ; Boet R; Chan MT; Gin T; Ng SC; Zee BC; Al-Shahi Salman R; Boiten J; Kuijsten H; Lavados PM; van Oostenbrugge RJ; Vandertop WP; Finfer S; O'Connor A; Yarad E; Firth R; McCallister R; Harrington T; Steinfort B; Faulder K; Assaad N; Morgan M; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N
    Stroke; 2015 Nov; 46(11):3190-3. PubMed ID: 26463689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
    van den Bergh WM; Algra A; van Kooten F; Dirven CM; van Gijn J; Vermeulen M; Rinkel GJ;
    Stroke; 2005 May; 36(5):1011-5. PubMed ID: 15790946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of decompressive craniectomy on functional outcomes and death in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Alotaibi NM; Elkarim GA; Samuel N; Ayling OGS; Guha D; Fallah A; Aldakkan A; Jaja BNR; de Oliveira Manoel AL; Ibrahim GM; Macdonald RL
    J Neurosurg; 2017 Dec; 127(6):1315-1325. PubMed ID: 28059660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium sulfate treatment improves outcome in patients with subarachnoid hemorrhage: a meta-analysis study.
    Huang B; Khatibi NH; Tong L; Yan P; Xie P; Zhang JH
    Transl Stroke Res; 2010 Jun; 1(2):108-12. PubMed ID: 23002400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Mori K; Yamamoto T; Nakao Y; Osada H; Hara Y; Oyama K; Esaki T
    Neurol Med Chir (Tokyo); 2009 Apr; 49(4):139-44; discussion 144-5. PubMed ID: 19398856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of magnesium sulfate infusion on cerebral perfusion in patients after aneurysmal SAH.
    Wong GK; Kwok R; Tang K; Yeung D; Ahuja A; King AD; Poon WS
    Acta Neurochir Suppl; 2010; 106():133-5. PubMed ID: 19812935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
    Takeuchi S; Mori K; Arimoto H; Fujii K; Nagatani K; Tomura S; Otani N; Osada H; Wada K
    BMC Neurol; 2014 Sep; 14():176. PubMed ID: 25201463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular free magnesium of brain and cerebral phosphorus-containing metabolites after subarachnoid hemorrhage and hypermagnesemic treatment: a ³¹P–magnetic resonance spectroscopy study. Clinical article.
    Wong GK; Yeung DK; Ahuja AT; King AD; Lam CW; Chan MT; Gin T; Poon WS
    J Neurosurg; 2010 Oct; 113(4):763-9. PubMed ID: 19911890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm as well as Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Matched Case-Control Analysis.
    Feulner J; Weidinger CS; Dörfler A; Birkholz T; Buchfelder M; Sommer B
    World Neurosurg; 2024 Jun; 186():e106-e113. PubMed ID: 38514031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Superoxide Dismutase Concentrations (SOD) in Plasma and CSF and Increased Circulating Total Antioxidant Capacity (TAC) Are Associated with Unfavorable Neurological Outcome after Aneurysmal Subarachnoid Hemorrhage.
    Krenzlin H; Wesp D; Schmitt J; Frenz C; Kurz E; Masomi-Bornwasser J; Lotz J; Ringel F; Kerz T; Keric N
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33809085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.